Interaction and molecular dynamics simulation study of Osimertinib (AstraZeneca 9291) anticancer drug with the EGFR kinase domain in native protein and mutated L844V and C797S
2019 ◽
Vol 120
(8)
◽
pp. 13046-13055
◽
2017 ◽
Vol 27
(3)
◽
pp. 805-817
◽
2019 ◽
Vol 11
(5)
◽
pp. 383-388
◽
2018 ◽
Vol 51
(34)
◽
pp. 345401
◽
2005 ◽
Vol 410
(1-3)
◽
pp. 54-58
◽
Keyword(s):